Pharmacological activity of deep-sea water: Examination of hyperlipemia prevention and medical treatment effect

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 11, 2003, Pages 1552-1559

  Yoshioka, Saburo ^a   Hamada, Atsuhide ^b   Cui, Tailin ^b   Yokota, Junko ^b   Yamamoto, Sayaka ^a   Kusunose, Masahiko ^a   Miyamura, Mitsuhiko ^a   Kyotani, Shojiro ^a   Kaneda, Ryou ^c   Tsutsui, Yasuyuki ^c   Odani, Kazuhiro ^d   Odani, Ichiro ^c   Nishioka, Yutaka ^a,b  

^a KOCHI MEDICAL SCHOOL HOSPITAL   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

^c Odani Kokufun Co Ltd   (Japan)

^d Muroto Marin Foods Co Ltd   (Japan)

Author keywords

Deep sea water; Hyperlipemia; Low density lipoprotein cholesterol; Mineral; Total cholesterol

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; CHOLESTEROL; LIPOPROTEIN; SEA WATER;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; DEEP SEA; HISTOPATHOLOGY; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIVER; MACROPHAGE; MALE; NONHUMAN; RABBIT; SAMPLE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CHOLESTEROL INTAKE; COMPARATIVE STUDY; METABOLISM;

ANIMALS; CHOLESTEROL; CHOLESTEROL, DIETARY; HYPERLIPIDEMIAS; LIPOPROTEINS; MALE; RABBITS; SEAWATER;

EID: 28244458902     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.26.1552     Document Type: Article

References (14)

1. Nakajima T., "21 Seikinojyunkanngatasigen," Midri Shobo, Tokyo, 2002, pp. 158-200 (in Japanese).
2. Nakajima T., "21 Seikinojyunkanngatasigen," Midri Shobo, Tokyo, 2002, pp. 68-91.
3. Nakajima T., "21 Seikinojyunkanngatasigen," Midri Shobo, Tokyo, 2002, pp. 217-238.
4. Takamiya T., Farumashia, 37, 785-789 (2001).
5. Fukushima H., Toki K., Nakatani H., J. Atheroscler. Res., 9, 57-64 (1969).
6. Shiba M., Yamamura S., Medicina, 32, 692-696 (1995).
7. Butatsu K., Tanaka Y., Kosugi Y., Nagasaki T., Jpn. J. Pharm. Health Care Sci., 27, 442-451 (2001).
8. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R., Am. J. Med., 62, 707-714 (1977).
9. Stampfer M. J., Hu F. B., Manson J. E., Rimm E. B., Willett W. C., N. Engl. J. Med., 343, 16-22 (2000).
10. Ian R. R., Mason B., Horne A., Ames R., Clearwater J., Bava U., Or-Walker B., Wu F., Evans M. C., Gamble G. D., Am. J. Med., 112, 343-347 (2002).
11. Price Evans D. A., Tariq M., Sujiata B., McCann G., Sobki S., Diabetes, Obesity and Metabolism, 3, 417-422 (2001).
12. Ouchi Y., Tabata R. E., Stergiopoulos K., Sato F., Hattori A., Orimo H., Arteriosclerosis, 10, 732-737 (1990).
13. Kovanen P. T., Brown M. S., Basu S. K., Bilheimer D. W., Joseph L. G., Proc. Natl. Acad. Sci. U.S.A., 78, 1396-1400 (1981).
14. Kobayashi M., Ishida F., Takahashi T., Tauchi K., Watanabe K., Ohmura I., Jpn. J. Pharmacol., 49, 125-133 (1989).